News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
Flagship’s computational Tissue Analysis (cTA™) tools support Summit’s DMD drug development
Flagship develops cTA™ tools and duplex IHC assays for muscle biopsy evaluation in support of disease-modifying therapies for Duchenne muscular dystrophy Granada, Spain – October
Flagship Biosciences to exhibit at ASCO Annual Meeting 2016
Booth #19122 June 3-7, McCormick Place, Chicago, IL May 25, 2016 – Westminster, CO – Flagship Biosciences, the leader in tissue image analysis, announced today
Dr. Nancy Gillett Joins Flagship’s Board of Directors
Former Charles River Laboratories CSO broadens Flagship’s leadership expertise Westminster, CO – May 3, 2016 – Flagship Biosciences, the leader in tissue image analysis, announced
Flagship to exhibit at AACR Annual Meeting 2016 with three immuno-oncology presentations
Booth #2634, April 16-20, Ernest N. Memorial Convention Center, New Orleans, LA Westminster, CO – April 13, 2016 – Flagship is pleased to announce that
Flagship Biosciences expands operations to meet tremendous industry growth demands
Escalated demand for Flagship’s tissue analysis capabilities are being driven by proven success. Westminster, CO – March 15, 2016 – Flagship’s track record of success
Flagship Biosciences and Beaufort, LLC partner to provide Clinical Trial Services for the Pharmaceutical Industry
Flagship Biosciences establishes partnership with Beaufort, an industry-leading CRO, to provide a full range of clinical trial services to advance initiatives that bring image analysis
